M. Borner

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin

M. Borner, Patrick Schöffski, Ronald de Wit et al. · European Journal of Cancer · 2002 · 314 citations

Intravenous Fluorouracil, Pharmacology, Patient Preference +4

A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1)

J. Randolph Hecht, Tanja Trarbach, E. Jaeger et al. · Journal of Clinical Oncology · 2005 · 201 citations

Tyrosine Kinase, Pathology, Surgery +17

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial

M. Borner, M. Castiglione, M. Bacchi et al. · Annals of Oncology · 1998 · 57 citations · Full text

Gastrointestinal Oncology, Medicine, Pharmacology +9

A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices

D Zahnd, Stefan Aebi, S. Rusterholz et al. · Annals of Oncology · 1999 · 32 citations · Full text

Device Therapy, Crossover Trial, Patient Selection +8